New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
Fake medicines have threatened citizens across the board--and borders--in wartime as well as peacetime. “Fake Penicillin, The Third Man and Operation Claptrap,” an article published in BMJ's online Christmas edition, looks at the history of falsified drugs and highlights what needs to be done to avert a global problem. Last year, for example, falsified ampicillin was discovered circulating in the Democratic Republic of the Congo, in bottles of 1,000 capsules and containing no detectable ampicillin." In the 21st century, government action remains key to fight both falsified and substandard medicines, advises the BMJ article.